As we step into 2026, we extend our warmest wishes for a healthy and happy New Year. At Kaifeng Mingren Pharmaceutical Co., Ltd, we remain deeply committed to discovering and delivering innovative medicines for patients around the world.Thank you for your partnership and trust. Here's to a future of

Kaifeng Mingren subsidiary company Lanzhou Bathcon Pharmaceutical made a brilliant appearance at SupplySide Global 2025 in the USA, with Berberine Hydrochloride selling well due to its strong advantagesIn October 2025, Lanzhou Bathcon Pharmaceutical Co., Ltd., a subsidiary of Kaifeng Mingren Pharmac

In 2025, Kaifeng Mingren Pharmaceutical Co., Ltd. will showcase its core products, including Berberine Hydrochloride, Tegoprazan series, and Phloroglucinol, at the CPHI Worldwide in Frankfurt, Germany (Booth No. 12.1H93).

Kaifeng Mingren Pharmaceutical Co.,LTD. was Established in 2002 with Registered capital 50 million RMB. It is committed to research & development, production and sales. Main business including: APIs, intermediates, CDMO, formulation. Manufacture site located in Kaifeng, Henan province with the area

Kaifeng Mingren Pharmaceutical Co.,LTD. was Established in 2002 with Registered capital 50 million RMB. It is committed to research & development, production and sales. Main business including: APIs, intermediates, CDMO, formulation. Manufacture site located in Kaifeng, Henan province with the area

Kaifeng Mingren Pharmaceutical Co.,LTD. was Established in 2002 with Registered capital 50 million RMB. It is committed to research & development, production and sales. Main business including: APIs, intermediates, CDMO, formulation. Manufacture site located in Kaifeng, Henan province with the area

Kaifeng Mingren Pharmaceutical Co.,LTD. was Established in 2002 with Registered capital 50 million RMB. It is committed to research & development, production and sales. Main business including: APIs, intermediates, CDMO, formulation. Manufacture site located in Kaifeng, Henan province with the area